CPRX
Catalyst Pharmaceuticals Partners, Inc.
$31.49
▲ +0.00%
NYSE · Healthcare · Biotechnology
· price updated 14d ago
Catalyst Pharmaceuticals Partners, Inc.
CPRX · NYSE · Healthcare · Biotechnology · price updated 14d ago
$31.49
▲ +0.00%
AI research · $31.49
Track CPRX for continuous AI research
price position
Where CPRX sits now
52-week range
Low$19.05
High$32.56
Today $31.49
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$755.9M
Total debt$2.2M
Net cash after debt$753.6M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Favorable · 27% below Sector avg · favorable
15.69x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
6.46x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
18.52x
EV / EBITDA
Operating value including debt
Strong · Under 12x operating cash earnings
10.14x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
78.8%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
24.5%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.00x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
7.10x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How CPRX compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $3.84B | 18.1 | +11.7% | 70 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Catalyst Pharmaceuticals Partners, Inc. (CPRX) stock
Catalyst Pharmaceuticals Partners, Inc. tracked in the US core universe. CPRX was +0.0% in the latest available session at $31.49. Its reported market value was $3.84B with a trailing P/E of 18.1. Latest reported revenue was $596.96M, changing +11.7% year over year, with $221.32M in net income.
Market snapshot updated Jul 21, 2026, 12:00 AM UTC.
- Latest available price
- $31.49
- Day change
- +0.0%
- Market cap
- $3.84B
- P/E (TTM)
- 18.1
- Revenue growth
- +11.7%
- Industry
- Biotechnology